The President of the European Commission, Ursula von der Leyen, announced on Friday 8 January that the institution had secured on behalf of the European Union a group purchase of 300 million doses (including 100 million doses as an option) of the Pfizer-BioNTech Covid-19 vaccine, in addition to the 300 million doses already approved in November 2020 (see EUROPE B12600A5).
“We have to vaccinate as many Europeans as possible as quickly as possible”, she said at a rare press conference at...